Cryoablation treatment for breast cancer in patients who can't have surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with breast cancer who are not candidates for surgery. It involves the use of cryoablation, a minimally invasive procedure that destroys cancer cells by freezing them, guided by ultrasound. The study aims to collect data on the safety and long-term outcomes of cryoablation in this specific patient population. Participants will be monitored over time to assess the effectiveness and safety of the treatment.

Why it matters

Who can join: the full rules

Eligibility Criteria:

* Diagnosis of breast cancer.
* Mass must be visible on ultrasound and \> 5 mm from skin.
* Not undergoing surgery, because:

  * Patient has a medical condition that would not allow sedation or general anesthesia
  * Surgery is not clinically indicated due to unresectable and/or metastatic disease
  * Surgery is not clinically indicated for another reason
  * Patient declines surgery
* At least 18 years old.
* Able to understand and willing to sign an IRB-approved written informed consent document.

Where it's running

• Washington University School of Medicine
  St Louis, Missouri, United States Recruiting

Study contacts

• Principal investigator: Heather Garrett, M.D. — Washington University School of Medicine
• Study coordinator: Heather Garrett, M.D.
• Email: hvgarrett@wustl.edu
• Phone: 314-454-5206

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CSF sample collection from people with metastatic breast cancer to see brain metastasis risk

  This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619534

• Precision MRI screening for dense breasts using Prognosia Breast risk score

  This study tests whether using the Prognosia Breast risk score with an MRI for women with very dense breasts and normal mammograms can reduce interval breast cancers.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT07277738

• ENLIGHT algorithm to find treatment options for advanced metastatic breast cancer

  This test uses the ENLIGHT algorithm to try to find approved drugs that might work better for adults with triple-negative or endocrine therapy–resistant metastatic breast cancer.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07067138

• ChatGPT and surgeon teamwork to improve breast reconstruction consultations

  This project will test whether ChatGPT-generated patient education materials help people preparing for breast reconstruction understand their options and feel more satisfied with their surgeon consultations.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT06981208

• Re‑irradiating the breast after a second lumpectomy

  This trial will test whether targeted re‑irradiation (IMRT) after a second lumpectomy is safe for people with ER+ / HER2‑ breast cancer who previously received breast radiation.

  Recruiting at 2 sites Baptist Health South Florida · Boca Raton, Florida and 1 other locations · NCT06867484

• Biomarker-guided treatment for breast cancer in postmenopausal women

  This study is testing if using specific biomarkers can help doctors choose better treatments for postmenopausal women with certain types of breast cancer, especially to see if some patients can skip chemotherapy.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT05837455

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.